ELV watch $291.41-295.59: Double Golden zone could mark BOTTOM ELV and all health insurance stocks have been dumping.
This is trying to break Double Golden zone $291.43-295.59
Looking for a Break-n-Retest for possible long entries.
Key facts today
Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
20.0 EUR
5.78 B EUR
170.79 B EUR
224.70 M
About Elevance Health, Inc.
Sector
Industry
CEO
Gail Koziara Boudreaux
Website
Headquarters
Indianapolis
Founded
1944
ISIN
US0367521038
FIGI
BBG00PKLK9Z5
Elevance Health, Inc. operates as a health company, which engages in improving lives and communities, and making healthcare simpler. It operates through the following segments: Health Benefits, CarelonRx, Carelon Services, and Corporate and Other. The Health Benefits segment offers a comprehensive suite of health plans and services to different customers. The CarelonRx segment markets and offers pharmacy services to affiliated health plan customers, as well as to external customers. The Carelon Services segment integrates physical, behavioral, pharmacy, and social services with the aim of delivering whole health affordably by offering a broad array of healthcare related services. The Corporate & Other segment includes businesses that do not individually meet the quantitative threshold for an operating segment. The company was founded in 1944 and is headquartered in Indianapolis, IN.
Related stocks
Elevance Health (ELV) – Trendline Reversal and Breakout SetupElevance Health ( NYSE:ELV ) is pushing higher along a rising trendline and is now testing a critical resistance zone around $340.67. A breakout above this level would signal a bullish reversal, with upside potential toward $402 (~18% move).
Entry trigger: Breakout above $340.67 with confirmation.
Elevance is losing the long term trendlineLosing such a large trendline is always a bad signal for a company.
The price can easily fall from 15 to 25% in the upcoming weeks or months, take care with this stock unless you are shorting.
This is especially significant while we are seeing Indexs, BTC and more doing new all time highs.
A SL
Potential 33% gain in ELVELV has a potential for a reversal for potentially 33% gain.
Using the Data Distribution with Extreme Clusters custom indicator, we can see that the stock is overextended on both the 5D chart (longer term) and 1D (shorter term) chart.
The last weekly bar ended up on a very high volume. Looking a
BUY ELVHealth Industry stocks have fallen a lot, ELV being one of many. Buying this stock at this current level anticipating price to respect this demand level.
Support Levels approaching$250 could potentially be a good opportunity to pick up Elevance. We are moving towards that level and I will be patient here as the downtrend is strong. The stock is representing deep value here and insiders agree as the CEO is been acquiring shares.
The stock has dropped 50% since it's recent hi
OVERSOLDLooking for back over 300 quickly CEO just $2.44 million strong Q2 revenue growth of 14.3% year-over-year to $49.42 billion, revenue is as good as it was at 500$ but expenses have been high. Institutions are loading here, good long-term hold if we need to continue DCA.
Elevance Health | ELV | Long at $286.00What are seeing in the healthcare and health insurance provider industry right now is destruction before a once-in-a-lifetime boom. The baby boomer generation is between 60 and 79 right now and the amount of healthcare service that will be needed to serve that population is staggering. Institutions
ELV (Elevance Health) – Catching the Knife or Catching Value?Elevance (ELV) just took a 12% hit after Q2 earnings missed estimates and full-year guidance was cut significantly. But here's the thing—the selloff may be overdone. The stock now trades at a forward P/E of ~10, well below industry peers, and is approaching multi-year support levels.
📥 Entry Plan
$ELV, Long, TP>10-15%NYSE:ELV , Long, TP>10-15%
Fundamentally the stock is good.
Choose an entry point and do not forget about a protective order if you are trading with leverage.
Don't risk it if you're not sure.
Good luck to everyone.
See all ideas
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.
ANTM5923067
Elevance Health, Inc. 5.85% 01-NOV-2064Yield to maturity
5.84%
Maturity date
Nov 1, 2064
ANTM4153492
Elevance Health, Inc. 4.85% 15-AUG-2054Yield to maturity
5.78%
Maturity date
Aug 15, 2054
ANTM5495609
Elevance Health, Inc. 6.1% 15-OCT-2052Yield to maturity
5.76%
Maturity date
Oct 15, 2052
ANTM5923066
Elevance Health, Inc. 5.7% 15-FEB-2055Yield to maturity
5.76%
Maturity date
Feb 15, 2055
US36752AS2
Elevance Health, Inc. 3.6% 15-MAR-2051Yield to maturity
5.76%
Maturity date
Mar 15, 2051
ANTM5815444
Elevance Health, Inc. 5.65% 15-JUN-2054Yield to maturity
5.75%
Maturity date
Jun 15, 2054
ELVH5534305
Elevance Health, Inc. 5.125% 15-FEB-2053Yield to maturity
5.74%
Maturity date
Feb 15, 2053
ANTM6169846
Elevance Health, Inc. 5.7% 15-SEP-2055Yield to maturity
5.74%
Maturity date
Sep 15, 2055
ANTM5405192
Elevance Health, Inc. 4.55% 15-MAY-2052Yield to maturity
5.73%
Maturity date
May 15, 2052
AE1J
Elevance Health, Inc. 4.375% 01-DEC-2047Yield to maturity
5.72%
Maturity date
Dec 1, 2047
ANTM4606236
Anthem, Inc. /Old/ 4.55% 01-MAR-2048Yield to maturity
5.71%
Maturity date
Mar 1, 2048
See all ELV bonds
Frequently Asked Questions
The current price of ELV is 314.1 EUR — it has increased by 1.09% in the past 24 hours. Watch Elevance Health, Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on VIE exchange Elevance Health, Inc. stocks are traded under the ticker ELV.
ELV stock has risen by 10.87% compared to the previous week, the month change is a 16.68% rise, over the last year Elevance Health, Inc. has showed a −29.54% decrease.
We've gathered analysts' opinions on Elevance Health, Inc. future price: according to them, ELV price has a max estimate of 381.79 EUR and a min estimate of 254.81 EUR. Watch ELV chart and read a more detailed Elevance Health, Inc. stock forecast: see what analysts think of Elevance Health, Inc. and suggest that you do with its stocks.
ELV stock is 1.09% volatile and has beta coefficient of 0.31. Track Elevance Health, Inc. stock price on the chart and check out the list of the most volatile stocks — is Elevance Health, Inc. there?
Today Elevance Health, Inc. has the market capitalization of 70.17 B, it has increased by 8.56% over the last week.
Yes, you can track Elevance Health, Inc. financials in yearly and quarterly reports right on TradingView.
Elevance Health, Inc. is going to release the next earnings report on Oct 21, 2025. Keep track of upcoming events with our Earnings Calendar.
ELV earnings for the last quarter are 7.50 EUR per share, whereas the estimation was 7.56 EUR resulting in a −0.78% surprise. The estimated earnings for the next quarter are 4.27 EUR per share. See more details about Elevance Health, Inc. earnings.
Elevance Health, Inc. revenue for the last quarter amounts to 41.95 B EUR, despite the estimated figure of 40.91 B EUR. In the next quarter, revenue is expected to reach 42.05 B EUR.
ELV net income for the last quarter is 1.48 B EUR, while the quarter before that showed 2.02 B EUR of net income which accounts for −26.67% change. Track more Elevance Health, Inc. financial stats to get the full picture.
Yes, ELV dividends are paid quarterly. The last dividend per share was 1.46 EUR. As of today, Dividend Yield (TTM)% is 1.87%. Tracking Elevance Health, Inc. dividends might help you take more informed decisions.
Elevance Health, Inc. dividend yield was 1.77% in 2024, and payout ratio reached 25.39%. The year before the numbers were 1.26% and 23.47% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Oct 10, 2025, the company has 104.2 K employees. See our rating of the largest employees — is Elevance Health, Inc. on this list?
Like other stocks, ELV shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Elevance Health, Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Elevance Health, Inc. technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Elevance Health, Inc. stock shows the sell signal. See more of Elevance Health, Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.